Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan

Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan

Kazuki Takano,1,2 Daishi Shimada,1 Shota Kashiwagura,1,3 Yasuhiro Kamioka,1,3 Maya Hariu,1,2 Yuji Watanabe,1,2 Masafumi Seki1 1Division of Infectious Diseases and Infection Control, Faculty of Medicine; 2Laboratory for Clinical Microbiology; 3Division of Pharmacy, Tohoku Medical and Pharmaceutical U...

Full description

Bibliographic Details
Main Authors:	Takano K, Shimada D, Kashiwagura S, Kamioka Y, Hariu M, Watanabe Y, Seki M
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-07-01
Series:	International Medical Case Reports Journal
Subjects:	non-tuberculosis mycobacterium macrolides clarithromycin fluoroquinolone sitafloxacin
Online Access:	https://www.dovepress.com/severe-pulmonary-mycobacterium-abscessus-cases-due-to-co-infection-wit-peer-reviewed-fulltext-article-IMCRJ

Similar Items

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
by: Yoshimasa Saito, et al.
Published: (2019-01-01)

Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates
by: Guo Q, et al.
Published: (2020-02-01)

A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus
by: Meenu Kaushal Sharma, et al.
Published: (2020-12-01)

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
by: Soichiro Sue, et al.
Published: (2021-02-01)

Sitafloxacin for Third-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review
by: Toshihiro Nishizawa, et al.
Published: (2021-06-01)

Clarithromycin Accumulation by Phagocytes and its Effect on Killing of Aggregatibacter Actinomycetemcomitans
by: Iskandar, Irma
Published: (2010)

Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
by: Yoshihiro Hirata, et al.
Published: (2016-10-01)

Efficacy of Clarithromycin Versus Methylprednisolone in the Treatment of Non-Eosinophilic and Eosinophilic Nasal Polyposis: A Randomized Controlled Trial
by: Jemilyn C. Gammad, et al.
Published: (2018-11-01)

Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates
by: Bing Li, et al.
Published: (2017-09-01)

Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis
by: Youngmok Park, et al.
Published: (2019-12-01)

PHARMACOKINETIC EVALUATION OF CLARITHROMYCIN ORAL CONTROLLED RELEASE MATRIX TABLETS FOR DESIRED BIOAVAILABILITY AND IMPROVED PATIENT COMPLIANCE
by: Muhammad Ramzan
Published: (2016-02-01)

Mycobacterium abscessus subspecies abscessus infection associated with cosmetic surgical procedures: Case series
by: C. Moreno-Izquierdo, et al.
Published: (2020-01-01)

Antimicrobial activities of sitafloxacin and comparators against the clinical isolates of less common nonfermenting Gram-negative bacteria
by: Guo, Y., et al.
Published: (2022)

Efficacy of clarithromycin on biofilm formation of methicillin-resistant <it>Staphylococcus pseudintermedius</it>
by: DiCicco Matthew, et al.
Published: (2012-11-01)

Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin
by: Maria Sjölund, et al.
Published: (2005-09-01)

Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin
by: Ashok Mahashur
Published: (2018-01-01)

CLINICAL EFFICIENCY OF CLARITHROMYCIN-MB IN COMPLEX THERAPY OF PATIENTS WITH NON-HOSPITAL PNEUMONIA
by: Tetiana Liadova, et al.
Published: (2020-12-01)

A Sensitive Liquid Chromatographic Method for the Analysis of Clarithromycin with Pre-Column Derivatization: Application to a Bioequivalence Study
by: Amir Farshchi, et al.
Published: (2009-03-01)

Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum
by: Barbara Kiesewetter, et al.
Published: (2018-04-01)

Efficacy and Safety of Sitafloxacin in the Treatment of Acute Bacterial Infection: A Meta-analysis of Randomized Controlled Trials
by: Chao-Kun Chen, et al.
Published: (2020-03-01)

Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial
by: Lojanapiwat B, et al.
Published: (2019-01-01)

Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections
by: Suk Hyeon Jeong, et al.
Published: (2017-07-01)

Effective Treatment of Intestinal Behçet's Disease with Long-Term, Low-Dose Clarithromycin
by: Yukiya Hakozaki, et al.
Published: (2013-03-01)

Multiple nontuberculous scrofulodermas showing dramatic response to clarithromycin
by: Kumar Parimalam, et al.
Published: (2015-01-01)

The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex
by: Satomi Takei, et al.
Published: (2020-10-01)

Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients
by: N.R. Hussein, et al.
Published: (2015-07-01)

RETROSPECTIVE ANALYSIS OF SLOVENIAN MYCOBACTERIUM AVIUM COMPLEX AND MYCOBACTERIUM ABSCESSUS COMPLEX ISOLATES AND MOLECULAR RESISTANCE PROFILE
by: S. Truden, et al.
Published: (2018-12-01)

Antimicrobial susceptibility profiles of Mycobacterium abscessus complex isolates from respiratory specimens in Shanghai, China
by: Qian Guo, et al.
Published: (2021-06-01)

Pulmonary Mycobacterium abscessus and response to treatment in an outpatient setting: Case series
by: Radha Gopalaswamy, et al.
Published: (2021-01-01)

Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex
by: Maiara dos Santos Carneiro, et al.

Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: A propensity score analysis
by: Yong Shik Kwon, et al.
Published: (2020-09-01)

WBC count and functional changes induced by co-administration of clofazimine and clarithromycin, in single and multiple doses, in Wistar rats
by: Flávia Aparecida Paina, et al.
Published: (2012-09-01)

Macrolide Resistance in Mycobacterium avium
by: Jensen-Cain, Donna Marie
Published: (2014)

Amputation of a finger in a patient with multidrug-resistant Mycobacterium marinum skin infection
by: Veraldi S, et al.
Published: (2018-10-01)

Macrolide Allergic Reactions
by: Kristy M. Shaeer, et al.
Published: (2019-09-01)

Probable disseminated <it>Mycobacterium abscessus</it> subspecies <it>bolletii</it> infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report
by: Colomba Claudia, et al.
Published: (2012-09-01)

Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy
by: Hendra Gunawan, et al.
Published: (2018-01-01)

Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin
by: Gennady B. Lapa, et al.
Published: (2017-01-01)

Prevalence of nontuberculous mycobacteria and high efficacy of D-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus
by: Khosravi AD, et al.
Published: (2018-12-01)

Successful treatment of refractory cutaneous infection caused by Mycobacterium marinum with a combined regimen containing amikacin
by: Huang Y, et al.
Published: (2012-11-01)